Salon Today
OCTOBER 2, 2024
Skin Laundry's CEO talks about how AI is alleviating stress from the frontline employees, elevating the client experience and helping the operation identify individual stars within their organization and quickly share the secrets of their success.
MedEsthetics
OCTOBER 2, 2024
"Consumers are becoming more cautious about their privacy, and they will only trust a brand’s personalized services if they know their data is being handled securely.
Salon Today
OCTOBER 2, 2024
In the hunt to discover the next national franchise in beauty and wellness, Zenoti launches Deep End, a Shark Tank-style competition in conjunction with its Innergize 2024 conference in Las Vegas, October 13-15.
MedEsthetics
OCTOBER 2, 2024
Here are the four must-watch industry and treatment trends from Aesthetic Next 6.0 that are shaping the global future of aesthetics.
Salon Today
OCTOBER 2, 2024
A new study reveals the states with the best and worst dental care, based on eight metrics, including adult smoking and binge drinking rates, and dentist visits
MedEsthetics
OCTOBER 2, 2024
Here are the four must-watch industry and treatment trends from Aesthetic Next 6.0 that are shaping the global future of aesthetics.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
National Laser Institute
OCTOBER 2, 2024
Are you stuck between the decision to enter into a trade school that gets you into the workforce sooner or. Read more » The post The Benefits of Trade School vs. Standard Four-Year Degree appeared first on National Laser Institute.
The Eco Well Podcasts
OCTOBER 2, 2024
This episode focused on the issue of misinformation and bad behaviour in the science and medical influencer space. Disclaimer, special attention was given to the rise of dermfluencers. While unethical behavior is happening across the expert community, I think dermfluencer may be having a moment right now in the skincare space. Which you’ll hear more about in this episode, which featured a roundtable discussion between dermatologist Anjali Mahto MD, cardiologist Rohin Francis MD , immunologist An
Dermatology Times
OCTOBER 2, 2024
Researchers ehind the review suggested that future research should prioritize large-scale trials to confirm abrocitinib's long-term safety and efficacy in various skin disorders.
The Dermatology Digest
OCTOBER 2, 2024
Jodi A. Mindell, PhD, the Associate Director of the Sleep Center at the Children’s Hospital of Philadelphia, reviews new research on sleep problems and allergic skin conditions such as eczema in infants and toddlers and offers tips on better bedtime rituals for affected families. Dr. Mindell recently presented the new data at American Academy of Pediatrics (AAP) National Conference & Exhibition in Orlando, FL.
North Dallas Dermatology Associates
OCTOBER 2, 2024
by Catherine Millet, MPAS, PA-C As summer winds down and the leaves begin to change, many of us turn our attention to our skin. Whether you’re looking to rejuvenate your complexion, reduce sun damage, or tackle signs of aging, fall is the perfect season to consider laser treatments and chemical peels. Here’s why this time of year is ideal for enhancing your skin’s health and appearance.
The Dermatology Digest
OCTOBER 2, 2024
JUVÉDERM VOLUMA XC for temple hollowing is now available nationwide, Allergan Aesthetics reports. Following its U.S. FDA approval in March 2024, JUVÉDERM VOLUMA XC is the first and only hyaluronic acid (HA) filler approved to treat moderate to severe temple hollowing in adults over 21. “In the months since approval, our focus has been on developing and implementing a robust training protocol designed to ensure providers are well versed in the science needed to inject the temple area,”
Dermatology Times
OCTOBER 2, 2024
Researchers found that MBEHQ treatment increased oxidative stress and proinflammatory cytokines IL-1β and IL-18 in patients with vitiligo.
Dermatology Times
OCTOBER 2, 2024
Enhanced education can reduce uncertainty among both patients and providers, with pharmacists playing a key role as primary sources of patient information.
Dermatology Times
OCTOBER 2, 2024
This marks the first head-to-head trial of an IL-17A/F inhibitor against an IL-23 inhibitor in psoriatic arthritis treatment.
Expert insights. Personalized for you.
111 
Let's personalize your content